Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
Status:
Terminated
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This is a study to be performed in Qatar that will look at the comparison of glycemic control
in patients with type 2 diabetes on insulin glargine U100 with insulin degludec over the
Ramadan period, to determine whether better glycemic control with fewer hypoglycemic episodes
can be achieved.